Thank you for donating!

You can donate using the following services.

Need support today?

Main menu

News

  1. 03.09.21

    Mandos Health Communication to The NPC1 Community

    Read more

  2. 24.08.21

    Orphazyme announces publication of results from its Phase 2/3 trial of arimoclomol in Niemann-Pick disease type C in the Journal of Inherited Metabolic Disease

    Read more

  3. 19.08.21

    IntraBio Reports Statistically Significant and Clinically Meaningful Improvements in the Use of IB1001 For Treatment of GM2 Gangliosidosis (Tay-Sachs and Sandhoff disease)

    Read more

  4. 02.07.21

    NPUK are hiring! (Fundraising Officer)

    Read more

  5. 30.06.21

    Orphazyme presents 36-month data supporting durable response to arimoclomol during Parseghian Scientific Conference for NPC Research

    Read more

2023 Niemann-Pick UK (NPUK). Registered Charity: England and Wales (1144406) / Scotland (SCO45407). Registered as a company limited by guarantee in England and Wales (07775835).

Donate today